IGF2BP1 and ovarian serous adenocarcinoma: The expression of IGF2BP1 in ovarian serous adenocarcinoma was higher than that in normal tissues; among ovarian clear cell adenocarcinoma, ovarian endometrioid adenocarcinoma, ovarian mucinous adenocarcinoma and ovarian serous adenocarcinoma, the expression of VIRMA was the highest in ovarian serous adenocarcinoma, and ZC3H13 was the highest in ovarian mucinous adenocarcinoma.